# Probiotic Ingestion and Isoagglutinin Titers

> **NCT00891787** · PHASE1 · COMPLETED · sponsor: **National Institutes of Health Clinical Center (CC)** · enrollment: 36 (actual)

## Conditions studied

- Isoagglutinin-Mediated Hemolysis
- Probiotic Toxicity

## Interventions

- **DIETARY_SUPPLEMENT:** Probiotic Supplement

## Key facts

- **NCT ID:** NCT00891787
- **Lead sponsor:** National Institutes of Health Clinical Center (CC)
- **Sponsor class:** NIH
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-04-28
- **Primary completion:** 2011-04-06
- **Final completion:** 2011-04-06
- **Target enrollment:** 36 (ACTUAL)
- **Last updated:** 2017-10-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00891787

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00891787, "Probiotic Ingestion and Isoagglutinin Titers". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT00891787. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*